Colorectal Neoplasms Clinical Trials in Changsha, Hunan
2 recruitingChangsha, Hunan, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
Phase 3
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
Colorectal Neoplasms
Merck Sharp & Dohme LLC100 enrolled32 locationsNCT05239741